HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Leo A Di; B Lesperance; S Korec; J Crown; P Simmonds; G von Minckwitz; JY Leroy; V Durbecq; J Isola; M Aapro; MJ Piccart; S Chan; D Larsimont; M Paesmans; K Friedrichs; T Pinter; V Cocquyt; E Murray; I Bodrogi; E Walpole

doi:10.1023/b:brea.0000036783.88387.47

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Leo A Di
, B Lesperance
, S Korec
, J Crown
, P Simmonds
, G von Minckwitz
, JY Leroy
, V Durbecq
, J Isola
, M Aapro
, MJ Piccart
, S Chan
, D Larsimont
, M Paesmans
, K Friedrichs
, T Pinter
, V Cocquyt
, E Murray
, I Bodrogi
, E Walpole

Kliinisen kemian yksikkö

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

57 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	197-206
Julkaisu	Breast Cancer Research and Treatment
Vuosikerta	86
Numero	3
DOI - pysyväislinkit	https://doi.org/10.1023/b:brea.0000036783.88387.47
Tila	Julkaistu - 2004
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

YK:n kestävän kehityksen tavoitteet

Tämä tuotos edistää seuraavia kestävän kehityksen tavoitteita:

SDG 3 – Hyvä terveys ja hyvinvointi

Pääsy asiakirjaan

10.1023/b:brea.0000036783.88387.47

Siteeraa tätä

Di, L. A., Lesperance, B., Korec, S., Crown, J., Simmonds, P., von Minckwitz, G., Leroy, JY., Durbecq, V., Isola, J., Aapro, M., Piccart, MJ., Chan, S., Larsimont, D., Paesmans, M., Friedrichs, K., Pinter, T., Cocquyt, V., Murray, E., Bodrogi, I., & Walpole, E. (2004). HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Breast Cancer Research and Treatment, 86(3), 197-206. https://doi.org/10.1023/b:brea.0000036783.88387.47

@article{83fe425ca64b4150b53d8f68916b269d,

title = "HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel",

author = "Di, \{Leo A\} and B Lesperance and S Korec and J Crown and P Simmonds and \{von Minckwitz\}, G and JY Leroy and V Durbecq and J Isola and M Aapro and MJ Piccart and S Chan and D Larsimont and M Paesmans and K Friedrichs and T Pinter and V Cocquyt and E Murray and I Bodrogi and E Walpole",

year = "2004",

doi = "10.1023/b:brea.0000036783.88387.47",

language = "English",

volume = "86",

pages = "197--206",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

Di, LA, Lesperance, B, Korec, S, Crown, J, Simmonds, P, von Minckwitz, G, Leroy, JY, Durbecq, V, Isola, J, Aapro, M, Piccart, MJ, Chan, S, Larsimont, D, Paesmans, M, Friedrichs, K, Pinter, T, Cocquyt, V, Murray, E, Bodrogi, I & Walpole, E 2004, 'HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel', Breast Cancer Research and Treatment, Vuosikerta 86, Nro 3, Sivut 197-206. https://doi.org/10.1023/b:brea.0000036783.88387.47

TY - JOUR

T1 - HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

AU - Di, Leo A

AU - Lesperance, B

AU - Korec, S

AU - Crown, J

AU - Simmonds, P

AU - von Minckwitz, G

AU - Leroy, JY

AU - Durbecq, V

AU - Isola, J

AU - Aapro, M

AU - Piccart, MJ

AU - Chan, S

AU - Larsimont, D

AU - Paesmans, M

AU - Friedrichs, K

AU - Pinter, T

AU - Cocquyt, V

AU - Murray, E

AU - Bodrogi, I

AU - Walpole, E

PY - 2004

Y1 - 2004

U2 - 10.1023/b:brea.0000036783.88387.47

DO - 10.1023/b:brea.0000036783.88387.47

M3 - Article

SN - 0167-6806

VL - 86

SP - 197

EP - 206

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -